NEW YORK (GenomeWeb News) – The European Union has awarded €5 million ($6.8 million) to fund over thirty proof-of-concept projects across Europe and in a broad range of fields, including life sciences research seeking to develop technologies toward commercialization.

The European Research Council provided up to €150,000 to each research project to help scientists push their pioneering "blue sky" basic science closer to the market.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.